2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

Avacopan for the Treatment of ANCA-Associated Vasculitis

(2021) David R.W. Jayne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

(2020) Michael Walsh et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study

(2019) Dimitrios Chanouzas et al.   BMC Nephrology

Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients

(2019) Cécile-Audrey Durel et al.   RHEUMATOLOGY

Kidney transplantation in ANCA-associated vasculitis

(2019) Michael S. Sagmeister et al.   JOURNAL OF NEPHROLOGY

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

(2017) Michael E. Wechsler et al.   NEW ENGLAND JOURNAL OF MEDICINE

Adding Azathioprine to Remission-Induction Glucocorticoids for Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss), Microscopic Polyangiitis, or Polyarteritis Nodosa Without Poor Prognosis Factors

(2017) Xavier Puéchal et al.   Arthritis & Rheumatology

Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial

(2017) Federica Maritati et al.   PLoS One

A number of factors explain why WHO guideline developers make strong recommendations inconsistent with GRADE guidance

(2016) Paul E. Alexander et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach

(2016) Ignacio Neumann et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Long-Term Followup of a Multicenter Cohort of 101 Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss)

(2016) Cécile-Audrey Durel et al.   ARTHRITIS CARE & RESEARCH

Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients

(2016) Etienne Crickx et al.   Arthritis & Rheumatology

Tracheobronchial Stenoses in Granulomatosis With Polyangiitis (Wegenerʼs)

(2015) Charlotte Girard et al.   MEDICINE

Long-term Outcomes of Rituximab Therapy in Ocular Granulomatosis with Polyangiitis

(2015) Lavnish Joshi et al.   OPHTHALMOLOGY

Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience

(2015) Benjamin Terrier et al.   RHEUMATOLOGY

Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg–Strauss)

(2014) A J Mohammad et al.   ANNALS OF THE RHEUMATIC DISEASES

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

(2014) Loïc Guillevin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

(2014) Hector G. Ortega et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term Outcome of Airway Stenosis in Granulomatosis With Polyangiitis (Wegener Granulomatosis)

(2014) Marcos Martinez Del Pero et al.   JAMA Otolaryngology-Head & Neck Surgery

Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody—Associated Vasculitis

(2013) Kirsten de Groot   ANNALS OF INTERNAL MEDICINE

GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations

(2013) Jeff Andrews et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Long-term follow-up of patients with severe ANCA-associated vasculitis comparing plasma exchange to intravenous methylprednisolone treatment is unclear

(2013) Michael Walsh et al.   KIDNEY INTERNATIONAL

Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

(2012) Rona M. Smith et al.   ARTHRITIS AND RHEUMATISM

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort

(2012) Cloé Comarmond et al.   ARTHRITIS AND RHEUMATISM

Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up

(2011) Lorraine Harper et al.   ANNALS OF THE RHEUMATIC DISEASES

The Five-Factor Score Revisited

(2011) Loïc Guillevin et al.   MEDICINE

Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis

(2011) G. Tomasson et al.   RHEUMATOLOGY

Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multicenter Experience

(2011) Duvuru Geetha et al.   TRANSPLANTATION

Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

(2010) Thomas F. Hiemstra et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

(2010) Rachel B. Jones et al.   NEW ENGLAND JOURNAL OF MEDICINE

Epidemiology of ANCA-associated Vasculitis

(2010) Eleana Ntatsaki et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis

(2008) Christian Pagnoux et al.   NEW ENGLAND JOURNAL OF MEDICINE

The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study

(2008) T Hauser et al.   THORAX

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

(2008) Gordon H Guyatt et al.   BMJ-British Medical Journal